Westpac Banking Corp’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Westpac Banking Corp’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-974	Closed	-$110K	–	787
2017 Q3	$110K	Hold	974	–	–	﹤0.01%	792
2017 Q2	$109K	Hold	974	–	–	﹤0.01%	840
2017 Q1	$114K	Buy	+974	New	+$108K	﹤0.01%	928
2016 Q3	–	Sell	-257	Closed	-$37.4K	–	877
2016 Q2	$37.4K	Buy	257 +189	+278%	+$26.8K	﹤0.01%	862
2016 Q1	$9.74K	Buy	+68	New	+$9.66K	﹤0.01%	855
2014 Q4	–	Sell	-39,400	Closed	-$6.06M	–	983
2014 Q3	$6.06M	Hold	39,400	–	–	0.06%	285
2014 Q2	$5.53M	Buy	+39,400	New	+$4.37M	0.05%	324

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Westpac Banking Corp's TARO Position: Q4 2017 in Review

Westpac Banking Corp sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 974 shares — an estimated $110K sold.

Westpac Banking Corp first reported a position in TARO in Q2 2014 and held it in 7 quarters. The position peaked at $6.06M in Q3 2014. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Westpac Banking Corp reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Westpac Banking Corp sold 974 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $110K.
Westpac Banking Corp first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 7 quarters.
Westpac Banking Corp's Taro Pharmaceutical Industries Ltd. position peaked at $6.06M in Q3 2014.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Westpac Banking Corp's 13F filing for Q4 2017, filed 18 Jan 2018.